News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

AVI BioPharma, Inc. Releases Good Neugene Animal Data



10/19/2005 5:13:21 PM

AVI BioPharma Inc. said Friday that its antisense drugs showed positive results against four lethal agents in preclinical studies conducted with Army researchers. Shares of AVI BioPharma Inc. rose 40 cents, or 14.8 percent, to $3.10 on the Nasdaq. Company shares have traded over the past 52 weeks in a range of $1.98 to $4.24.

Read at AP
Read at BioSpace.com


comments powered by Disqus
AP
BioSpace.com
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES